Back
NovaBay Pharmaceuticals Stock Price Chart
Sponsored
NBY
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
NBY
NovaBay Pharmaceuticals
Last Price:
0.50
Seasonality Move:
-14.79%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
NovaBay Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.48 | Buy |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.89 | Sell |
200-day SMA: | 3.84 | Sell |
8-day EMA: | 0.49 | Buy |
20-day EMA: | 0.53 | Sell |
50-day EMA: | 0.97 | Sell |
200-day EMA: | 8.42 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | -38478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.53) | Buy |
Bollinger Bands (100): | (0.61 - 3.39) | Sell |
NovaBay Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.51 while NBY 8-day simple moving average is 0.48, which is a Buy signal.
- The stock price of NBY is 0.51 while NovaBay Pharmaceuticals 20-day SMA is 0.49, which makes it a Buy.
- NovaBay Pharmaceuticals 50-day simple moving average is 0.89 while NBY share price is 0.51, making it a Sell technically.
- NBY stock price is 0.51 and NovaBay Pharmaceuticals 200-day simple moving average is 3.84, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
26
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
2.49M
Price in USD:
0.51
Share Volume:
74.3K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
17.74
52-Week Low:
0.36
Sell
26
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?
The NovaBay Pharmaceuticals stock price is 0.51 USD today. -
Will NBY stock go up or go down?
NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NovaBay Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.51 while NBY 8-day exponential moving average is 0.49, which is a Buy signal.
- The stock price of NBY is 0.51 while NovaBay Pharmaceuticals 20-day EMA is 0.53, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day exponential moving average is 0.97 while NBY share price is 0.51, making it a Sell technically.
- NBY stock price is 0.51 and NovaBay Pharmaceuticals 200-day simple moving average is 8.42, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
- NBY Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting NovaBay Pharmaceuticals is a Sell
- NovaBay Pharmaceuticals Relative Strength Index (RSI) is 38.38, which suggest NovaBay Pharmaceuticals is oversold
- The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.47 - 0.53), which suggest NovaBay Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.61 - 3.39), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.